The Molecular Role of Immune Cells in Dilated Cardiomyopathy
Dilated cardiomyopathy (DCM) is a rare and severe condition characterized by chamber dilation and impaired contraction of the left ventricle. It constitutes a fundamental etiology for profound heart failure and abrupt cardiac demise, rendering it a prominent clinical indication for heart transplanta...
Main Authors: | Enping Wang, Ruofan Zhou, Tiange Li, Yimin Hua, Kaiyu Zhou, Yifei Li, Shuhua Luo, Qi An |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/59/7/1246 |
Similar Items
-
Immune cells and related cytokines in dilated cardiomyopathy
by: Jingdi Zhang, et al.
Published: (2024-02-01) -
Identification of Novel Targets for Treatment of Dilated Cardiomyopathy Based on the Ferroptosis and Immune Heterogeneity
by: Lu H, et al.
Published: (2023-06-01) -
Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy
by: Angita Jain, et al.
Published: (2021-05-01) -
Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy
by: Zhe Lei, et al.
Published: (2024-02-01) -
Reversible dilative cardiomyopathy after electrical injury: a case report
by: Eirini Liodaki, et al.
Published: (2018-11-01)